Fundraising September 15, 2024 – October 1, 2024 About fundraising
1

TNFα in the millennium twilight

Year:
2000
Language:
english
File:
PDF, 29 KB
english, 2000
9

Par-4: A common facilitator/enhancer of extrinsic and intrinsic pathways of apoptosis

Year:
2006
Language:
english
File:
PDF, 70 KB
english, 2006
17

Lingering biologic dilemmas about the status of the progenitor cells in myelodysplasia

Year:
2003
Language:
english
File:
PDF, 197 KB
english, 2003
18

Targeting cyclin D1 for high risk myelodysplastic syndromes

Year:
2012
Language:
english
File:
PDF, 112 KB
english, 2012
23

Caspases and apoptosis in myelodysplastic syndromes

Year:
2000
Language:
english
File:
PDF, 31 KB
english, 2000
27

Defining the dynamics of self-assembled Fas-receptor activation

Year:
2002
Language:
english
File:
PDF, 2.21 MB
english, 2002
29

Short communications and case reports—Who cares?

Year:
2012
Language:
english
File:
PDF, 73 KB
english, 2012
30

Cytogenetic testing for therapeutic indication in cancer

Year:
2005
Language:
english
File:
PDF, 284 KB
english, 2005
33

Advances in erythropoietic growth factor therapy for myelodysplastic syndromes

Year:
2006
Language:
english
File:
PDF, 210 KB
english, 2006
35

Erythropoiesis-stimulating agents versus RBC transfusion in MDS: comparison of long-term outcomes

Year:
2007
Language:
english
File:
PDF, 482 KB
english, 2007
36

Clinical implications of advanced molecular cytogenetics in cancer

Year:
2004
Language:
english
File:
PDF, 301 KB
english, 2004